Purchases a GEA Pharma-SD type PSD-4 solvent-capable spray dryer designed to produce commercial batches up to 500 kg.

Fujifilm Biotechnologies is unveiling a precision purification tool, ShunzymeX, that simplifies downstream processing for ...

Duvakitug is currently in phase 3 trials for ulcerative colitis and Crohn’s disease.

Codexis has agreed to manufacture 50 grams of siRNA using its proprietary ECO Synthesis manufacturing platform to support ...

Will house process development and analytical services for advanced peptide API production from development through commercialization.

Antheia has expanded the scope of its second project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium, securing an additional $9 million.

Rovadicitinib is approved in China for myelofibrosis and is in late-stage development for chronic graft-versus-host disease.

Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting KIT-driven cancers.

Moderna has entered into a settlement agreement resolving all worldwide Arbutus Biopharma Corporation/Genevant Sciences GmbH ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Latigo Biotherapeutics is appointing Neha Krishnamohan as both Chief Financial Officer (CFO) and Chief Business Officer (CBO) ...

Kivu Bioscience is naming Brunilda Shtylla Chief Business Officer, with Shtylla assuming the same role she held at Sutro Biopharma.